InspireMD Inc Stock Nyse
Equities
US45779A3095
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Mar. 06 | Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024 | |
Mar. 06 | Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M | MT |
Financials (USD)
Sales 2024 * | 7.09M | Sales 2025 * | 14.65M | Capitalization | 50.22M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 7.08 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.43 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.86% |
Latest transcript on InspireMD Inc
Managers | Title | Age | Since |
---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 60 | 19-12-31 |
Craig Shore
DFI | Director of Finance/CFO | 62 | 11-03-30 |
Juan Rigla
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Roubin
BRD | Director/Board Member | 76 | 20-10-12 |
Marvin Slosman
CEO | Chief Executive Officer | 60 | 19-12-31 |
Thomas Kester
BRD | Director/Board Member | 77 | 16-09-05 |
1st Jan change | Capi. | |
---|---|---|
-4.36% | 184B | |
-3.87% | 105B | |
-4.38% | 67.09B | |
+8.23% | 51.61B | |
+15.54% | 47.55B | |
-2.13% | 39.95B | |
+7.16% | 27.62B | |
-12.48% | 25.74B | |
-1.68% | 25.62B |